<VariationArchive VariationID="2412504" VariationName="NM_001032386.2(SUOX):c.423del (p.Val142fs)" VariationType="Deletion" Accession="VCV002412504" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2023-02-08" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2400357" VariationID="2412504">
      <GeneList>
        <Gene Symbol="SUOX" FullName="sulfite oxidase" GeneID="6821" HGNC_ID="HGNC:11460" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="55997276" stop="56005525" display_start="55997276" display_stop="56005525" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56391042" stop="56399308" display_start="56391042" display_stop="56399308" Strand="+" />
          </Location>
          <OMIM>606887</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001032386.2(SUOX):c.423del (p.Val142fs)</Name>
      <CanonicalSPDI>NC_000012.12:56003811:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="56003812" stop="56003812" display_start="56003812" display_stop="56003812" variantLength="1" positionVCF="56003811" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56397596" stop="56397596" display_start="56397596" display_stop="56397596" variantLength="1" positionVCF="56397595" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V142fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.56397596del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.56397596del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.56003812del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.56003812del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008136.1" sequenceAccession="NG_008136" sequenceVersion="1" change="g.11554del">
            <Expression>NG_008136.1:g.11554del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000456.3" sequenceAccession="NM_000456" sequenceVersion="3" change="c.423del">
            <Expression>NM_000456.3:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000447.2" sequenceAccession="NP_000447" sequenceVersion="2" change="p.Val142fs">
            <Expression>NP_000447.2:p.Val142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032386.2" sequenceAccession="NM_001032386" sequenceVersion="2" change="c.423del" MANESelect="true">
            <Expression>NM_001032386.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027558.1" sequenceAccession="NP_001027558" sequenceVersion="1" change="p.Val142fs">
            <Expression>NP_001027558.1:p.Val142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032387.2" sequenceAccession="NM_001032387" sequenceVersion="2" change="c.423del">
            <Expression>NM_001032387.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027559.1" sequenceAccession="NP_001027559" sequenceVersion="1" change="p.Val142fs">
            <Expression>NP_001027559.1:p.Val142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001032386.2(SUOX):c.423del (p.Val142fs) AND Inborn genetic diseases" Accession="RCV002809993" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001032386.2(SUOX):c.423del (p.Val142fs) AND Sulfite oxidase deficiency" Accession="RCV003638911" Version="1">
        <ClassifiedConditionList TraitSetID="6507">
          <ClassifiedCondition DB="MedGen" ID="C0268624">Sulfite oxidase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12112661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17940249</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23994568</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28980090</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9428520</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3860" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Sulfite oxidase deficiency</ElementValue>
                <XRef ID="Sulfite+oxidase+deficiency/6924" DB="Genetic Alliance" />
                <XRef ID="HP:0003643" DB="Human Phenotype Ontology" />
                <XRef ID="367368009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated sulfite oxidase deficiency</ElementValue>
                <XRef ID="MONDO:0010089" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of isolated sulfite oxidase deficiency ranges from classic early-onset (severe) disease to late-onset (mild) disease. Classic ISOD is characterized in the first few hours to days of life by intractable seizures, feeding difficulties, and rapidly progressive encephalopathy manifest as abnormal tone (especially opisthotonus, spastic quadriplegia, and pyramidal signs) followed by progressive microcephaly and profound intellectual disability. Lens subluxation or dislocation, another characteristic finding, may be evident after the newborn period. Children usually die during the first few months of life. Late-onset ISOD manifests between ages six and 18 months and is characterized by ectopia lentis (variably present), developmental delay/regression, movement disorder characterized by dystonia and choreoathetosis, ataxia, and (rarely) acute hemiplegia as a result of metabolic stroke. The clinical course may be progressive or episodic. In the episodic form encephalopathy, dystonia, choreoathetosis, and/or ataxia are intermittent.</Attribute>
                <XRef ID="NBK453433" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5062" />
                <XRef ID="5062" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28933809</ID>
                <ID Source="BookShelf">NBK453433</ID>
              </Citation>
              <XRef ID="833" DB="Orphanet" />
              <XRef ID="99731" DB="Orphanet" />
              <XRef ID="C0268624" DB="MedGen" />
              <XRef ID="MONDO:0010089" DB="MONDO" />
              <XRef Type="MIM" ID="272300" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003643" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8179537" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="16785730|MedGen:C0268624" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004391534" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17940249</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28980090</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val142Phefs*19) in the SUOX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 404 amino acid(s) of the SUOX protein. This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SUOX-related conditions. ClinVar contains an entry for this variant (Variation ID: 2412504). This variant disrupts a region of the SUOX protein in which other variant(s) (p.Arg529*) have been determined to be pathogenic (PMID: 17940249, 28980090). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.56397596del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268624" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6449977" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a6060133|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003758631" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9428520</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23994568</ID>
          </Citation>
          <Comment>The c.423delT (p.V142Ffs*19) alteration, located in exon 6 (coding exon 3) of the SUOX gene, consists of a deletion of one nucleotide at position 423, causing a translational frameshift with a predicted alternate stop codon after 19 amino acids. This alteration occurs at the 3' terminus of the SUOX gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 403 amino acids of the protein. However, premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). Based on data from gnomAD, the c.423delT allele has an overall frequency of &lt;0.01% (1/251420) total alleles studied. The highest observed frequency was &lt;0.01% (1/34584) of Latino alleles. Other truncating alterations downstream have been observed in individuals with a personal and/or family history that is consistent with SUOX-related disease (Kisker, 1997; Johnson, 2002; Cho, 2013). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000456.2:c.423delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6449977" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8179537" TraitType="Disease" MappingType="XRef" MappingValue="C0268624" MappingRef="MedGen">
        <MedGen CUI="C0268624" Name="Sulfite oxidase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

